Evidence map›Paper›PMID 42144870›Full record

ArticleProtein science : a publication of the Protein Society2026

Computational design of a soluble mimic of the outer membrane LPS transport protein LptD suitable for screening of antibiotics.

Wenzhao Dai, Wenxuan Hu, Matthias Schuster, Laetitia Rožić, Bernd Roschitzki, Oliver Zerbe

Abstract read
In one paragraph

Article in Protein science : a publication of the Protein Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Wenzhao DaiDepartment of Chemistry, University of Zurich, Zurich, Switzerland.
Wenxuan HuDepartment of Chemistry, University of Zurich, Zurich, Switzerland.
Matthias SchusterDepartment of Chemistry, University of Zurich, Zurich, Switzerland.
Laetitia RožićDepartment of Chemistry, University of Zurich, Zurich, Switzerland.
Bernd RoschitzkiFunctional Genomics Center Zürich (FGCZ), Zurich, Switzerland.
Oliver ZerbeDepartment of Chemistry, University of Zurich, Zurich, Switzerland.ORCID 0000-0003-0475-438X

Funding

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung 200021_184744UZH FoundationVontobel-Stiftung
6 · The paper itself

Abstract

Lipopolysaccharides (LPS) are the principal chemical component of the outer leaflet of Gram-negative bacteria and constitute the first barrier of defense against foreign molecules. Inhibition of LPS transport presents a novel concept for antibiotic discovery, and components of the transport bridge are targets of antimicrobial peptides. LptD, a β-barrel outer membrane protein, the terminal module of the Lpt transport bridge, however, remains largely unexplored as a drug target as its biosynthesis is complicated and screens against membrane proteins are challenging. Herein, we report a computationally designed, soluble E. coli LptD periplasmic epitope mimic, LptDm. We describe an efficient in silico design pipeline that includes verification of interactions of LptD mimics with the cognate ligands LptA and thanatin using nuclear magnetic resonance (NMR) and size-exclusions chromatography (SEC) techniques. A small peptide library demonstrates that LptDm allows for selection of high-affinity binders against LptD, rendering LptD accessible to modern drug discovery approaches.

Indexed as

Anti-Bacterial AgentsBacterial Outer Membrane ProteinsEscherichia coliEscherichia coli ProteinsLipopolysaccharidesAmino Acid SequenceCarrier ProteinsModels, MolecularNuclear Magnetic Resonance, BiomolecularPeptide LibrarySolubilityAnti-Bacterial AgentsBacterial Outer Membrane ProteinsCarrier ProteinsEscherichia coli ProteinsLipopolysaccharidesLptA protein, E coliLptD protein, E coliPeptide LibraryantibioticsGram‐negative bacteriaLPS transportprotein designprotein–protein interaction inhibitor

Identifiers

PMID42144870
PMCPMC13181209

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.